Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Diagnosis, treatment, and prevention of Clostridium difficile colitis.

Ward CO.

Consult Pharm. 2003 Dec;18(12):1050-4.

PMID:
16563071
2.

Past, present, and future therapies for Clostridium difficile-associated disease.

Surowiec D, Kuyumjian AG, Wynd MA, Cicogna CE.

Ann Pharmacother. 2006 Dec;40(12):2155-63. Epub 2006 Dec 5. Review.

PMID:
17148650
3.

Surgical aspects of Clostridium difficile colitis.

Bradbury AW, Barrett S.

Br J Surg. 1997 Feb;84(2):150-9. Review.

PMID:
9052424
4.

Fulminant Clostridium difficile colitis.

Adams SD, Mercer DW.

Curr Opin Crit Care. 2007 Aug;13(4):450-5. Review.

PMID:
17599017
5.

Clinical review of the management of fulminant clostridium difficile infection.

Jaber MR, Olafsson S, Fung WL, Reeves ME.

Am J Gastroenterol. 2008 Dec;103(12):3195-203; quiz 3204. doi: 10.1111/j.1572-0241.2008.02198.x. Epub 2008 Oct 1. Review.

PMID:
18853982
6.

National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.

Jarvis WR, Schlosser J, Jarvis AA, Chinn RY.

Am J Infect Control. 2009 May;37(4):263-70. doi: 10.1016/j.ajic.2009.01.001. Epub 2009 Mar 10.

PMID:
19278754
7.

A study of Clostridium difficile-associated disease at King Chulalongkorn Memorial Hospital, Thailand.

Pupaibool J, Khantipong M, Suankratay C.

J Med Assoc Thai. 2008 Jan;91(1):37-43.

PMID:
18386542
8.

Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality.

Sailhamer EA, Carson K, Chang Y, Zacharias N, Spaniolas K, Tabbara M, Alam HB, DeMoya MA, Velmahos GC.

Arch Surg. 2009 May;144(5):433-9; discussion 439-40. doi: 10.1001/archsurg.2009.51.

PMID:
19451485
9.

Case-controlled review of Clostridium difficile-associated diarrhoea in southern Tasmania.

Halim HA, Peterson GM, Friesen WT, Ott AK.

J Clin Pharm Ther. 1997 Oct-Dec;22(5-6):391-7.

PMID:
19160724
10.

Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.

McFarland LV, Clarridge JE, Beneda HW, Raugi GJ.

Clin Infect Dis. 2007 Nov 1;45(9):1141-51. Epub 2007 Sep 26.

PMID:
17918075
11.

Impact of Clostridium difficile on inflammatory bowel disease.

Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, Skaros S, Weber LR, Komorowski RA, Knox JF, Emmons J, Bajaj JS, Binion DG.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):345-51.

PMID:
17368234
12.
13.

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection.

Dial S, Kezouh A, Dascal A, Barkun A, Suissa S.

CMAJ. 2008 Oct 7;179(8):767-72. doi: 10.1503/cmaj.071812.

14.

Defining surgical therapy for pseudomembranous colitis with toxic megacolon.

Berman L, Carling T, Fitzgerald TN, Bell RL, Duffy AJ, Longo WE, Roberts KE.

J Clin Gastroenterol. 2008 May-Jun;42(5):476-80. doi: 10.1097/MCG.0b013e31804bbe12.

PMID:
18277885
15.

Medical diagnoses and procedures associated with clostridium difficile colitis.

Buchner AM, Sonnenberg A.

Am J Gastroenterol. 2001 Mar;96(3):766-72.

PMID:
11280548
16.

Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.

Aseeri M, Schroeder T, Kramer J, Zackula R.

Am J Gastroenterol. 2008 Sep;103(9):2308-13. doi: 10.1111/j.1572-0241.2008.01975.x. Epub 2008 Aug 12.

PMID:
18702653
17.

Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.

Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN.

Arch Surg. 2007 Jul;142(7):624-31; discussion 631.

PMID:
17638799
18.

Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases.

Ricciardi R, Ogilvie JW Jr, Roberts PL, Marcello PW, Concannon TW, Baxter NN.

Dis Colon Rectum. 2009 Jan;52(1):40-5. doi: 10.1007/DCR.0b013e31819733fd.

PMID:
19273954
19.

Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.

Al-Nassir WN, Sethi AK, Nerandzic MM, Bobulsky GS, Jump RL, Donskey CJ.

Clin Infect Dis. 2008 Jul 1;47(1):56-62. doi: 10.1086/588293.

PMID:
18491964
20.

Risk factors for the development of fulminant Clostridium difficile colitis.

Greenstein AJ, Byrn JC, Zhang LP, Swedish KA, Jahn AE, Divino CM.

Surgery. 2008 May;143(5):623-9. doi: 10.1016/j.surg.2007.12.008. Epub 2008 Mar 24.

PMID:
18436010

Supplemental Content

Support Center